Member Info for lostinspace69

if body language counts for anything, then this CEO is a "buy" !!!

Interesting article about a mutation to the virus which significantly increases its ability to infect;

https://www.technologynetworks.com/immunology/news/mutation-of-coronavirus-is-significantly-increasing-its-ability-to-infect-336067

I watched the evening presentation and was very impressed. I get the feeling that Alistair and Co. are keen to secure long term holders in the company, who buy into the long term vision. I don't think they care about the short term whims of traders, and neither should they. An AVACTA is for life, not just for COVID. Have a good day.

amazing find and thanks for sharing. I see Sona also on the panel. Out of interest, can anyone confirm how their LFT works? Is it a nasal swab and does it have to be mixed with a solution before being applied to the test strip? I am just wondering how the user experience differs between ours and theirs?

LIKE!

HD, I lie your thinking. This IS happening.

Need to step on the gas as more competition will surface and first mover advantage cannot be underestimated, particularly in this situation. I note ODX have this morning announced the development of a Lateral Flow Test to detect for presence of COVID.

hants, agree completely. I think this weekend just gone will prove to be a turning point, with new infections on the rise again. A combination of factors, including the weather (rain and cold) and large scale public demonstrations, but also a sense of complacency that I have witnessed amongst my own friends and family.

I have taken the opportunity to top up. Not too worried about short term price movements as I am confident that near term newsflow will be both strong and positive.

Any thoughts on why this?

08-Jun-20 12:20:37 120.00 193,902 Sell* 141.00 143.00 232.68k

timster, i agree the media and public are bored with Covid and consensus opinion is the problem is going away. However, you only need to take a look at these latest numbers from US to see a second wave is happening already;

https://twitter.com/cfishman/status/1269781054635868161

Evidence emerging of a second wave n the US;

https://twitter.com/cfishman/status/1269781054635868161

this is like taking candy from a baby. BOOM!

so happy I found this forum and would like to say again how much I appreciate all the detailed research and knowledge sharing that takes place here.

Love hearing these stories. I am holding 8.7m in my ISA at 2.8p. 1.3m in my SIPP at 8.5p and another 3m at 8.7p in my share dealing account. 13m total. I see this investment as safer than cash in the current crazy world we are living in lol

thanks for the bump. this has made my day. woohoo!

I always believe its really important that you; a) do your own research, b) feel comfortable with your investment decisions. No point in others trying to convince you. If you don't like the look of this company, don't invest

You should get an email that looks something like this, then you know the admission date;

Congratulations! Avacta Group Plc () has completed its Fundraise on the PrimaryBid platform, your subscription was successful and you have been allocated the following shares:

Avacta Group Plc

Offer Price: 120p
Offer Allocation (# of shares): 20000
Subscription Paid: £24020
Settlement Fees: £20
Total Paid: £24000
Our Reference: xxxx

Your Share Transfer

You will receive your shares on or shortly after admission date, in line with the transfer timetable of your share account provider.


Application will be made for the Offer Shares, to be admitted to trading on London Stock Exchange ("Admission"). Dealings are expected to commence at 8.00 a.m. on 23 June 2020, at the same time as the closing of the Subscription, Conversion and the Placing.



The PrimaryBid Offer is conditional upon the passing of the resolutions (the "Resolutions") at the general meeting of the Company, being approved by Shareholders at a General Meeting being held on 22 June 2020.

White House health advisor Dr. Anthony Fauci said he worries about the “durability” of a potential coronavirus vaccine, saying there’s a chance it may not provide long-term immunity.

If Covid-19 acts like other coronaviruses, “it likely isn’t going to be a long duration of immunity,” Fauci, director of the National Institute of Allergy and Infectious Diseases, told JAMA Editor Howard Bauchner.

If this proves to be the case, then it would seem that neutralising therapies such as those being developed by AVACTA would potentially be more beneficial than a vaccine?

either way, the long term investment thesis remains intact. Nothing has changed. Ignore short term volatility. It isn't a reflection on the potential of the company.